JPH04261122A - Angiotensinase activity inhibitor contained in leguminous plant seed - Google Patents
Angiotensinase activity inhibitor contained in leguminous plant seedInfo
- Publication number
- JPH04261122A JPH04261122A JP3040511A JP4051191A JPH04261122A JP H04261122 A JPH04261122 A JP H04261122A JP 3040511 A JP3040511 A JP 3040511A JP 4051191 A JP4051191 A JP 4051191A JP H04261122 A JPH04261122 A JP H04261122A
- Authority
- JP
- Japan
- Prior art keywords
- beans
- angiotensin
- converting enzyme
- angiotensinase
- soybeans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010058865 angiotensinase Proteins 0.000 title abstract 4
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title description 11
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 67
- 244000068988 Glycine max Species 0.000 claims abstract description 30
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 30
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 21
- 240000004713 Pisum sativum Species 0.000 claims abstract description 13
- 235000010582 Pisum sativum Nutrition 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 10
- 241000196324 Embryophyta Species 0.000 claims abstract description 9
- 238000004255 ion exchange chromatography Methods 0.000 claims abstract description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 65
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 claims description 21
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 claims description 21
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 claims description 21
- 235000006089 Phaseolus angularis Nutrition 0.000 claims description 12
- 240000007098 Vigna angularis Species 0.000 claims description 12
- 239000006286 aqueous extract Substances 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 244000045930 Phaseolus coccineus Species 0.000 claims description 2
- 235000010632 Phaseolus coccineus Nutrition 0.000 claims description 2
- 239000002220 antihypertensive agent Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 102000015427 Angiotensins Human genes 0.000 claims 1
- 108010064733 Angiotensins Proteins 0.000 claims 1
- 229940030600 antihypertensive agent Drugs 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- ONSIBMFFLJKTPT-UHFFFAOYSA-L zinc;2,3,4,5,6-pentachlorobenzenethiolate Chemical compound [Zn+2].[S-]C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl.[S-]C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl ONSIBMFFLJKTPT-UHFFFAOYSA-L 0.000 claims 1
- 244000066764 Ailanthus triphysa Species 0.000 abstract description 11
- 235000010726 Vigna sinensis Nutrition 0.000 abstract description 11
- 239000000284 extract Substances 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 3
- 230000001077 hypotensive effect Effects 0.000 abstract description 2
- 238000005259 measurement Methods 0.000 abstract description 2
- 240000001417 Vigna umbellata Species 0.000 abstract 1
- 235000011453 Vigna umbellata Nutrition 0.000 abstract 1
- 244000042314 Vigna unguiculata Species 0.000 abstract 1
- 235000021332 kidney beans Nutrition 0.000 abstract 1
- 241000219977 Vigna Species 0.000 description 11
- 241001107116 Castanospermum australe Species 0.000 description 10
- 241000282376 Panthera tigris Species 0.000 description 10
- 235000021279 black bean Nutrition 0.000 description 10
- 235000010711 Vigna angularis Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000005541 ACE inhibitor Substances 0.000 description 7
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 4
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- AAXWBCKQYLBQKY-IRXDYDNUSA-N (2s)-2-[[(2s)-2-[(2-benzamidoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)C=1C=CC=CC=1)C1=CN=CN1 AAXWBCKQYLBQKY-IRXDYDNUSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 101800004538 Bradykinin Proteins 0.000 description 2
- 102400000967 Bradykinin Human genes 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 108010016268 hippuryl-histidyl-leucine Proteins 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 102400000345 Angiotensin-2 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- 241000219732 Lathyrus cicera Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002315 pressor effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000000512 proximal kidney tubule Anatomy 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、豆科植物ファゼオラス
・ブルガリス(エル)〔Phaseolus vulg
aris(L).大正キントキ豆、白いんげん〕,ファ
ゼオラス・コクシネウス(エル)〔Phaseolus
coccineus (L).とら豆,紫花豆,白花
豆〕,ファゼオラス・アンギュラリス.ダヴリュ.エフ
.ワイト〔Phaseolus angularis
W.F.Wight,あずき〕,フィグナ・シネンシス
.エンドル〔Vigna sineusis Endl
.ささげ〕,ピスム・サチブム(エル)〔Pisum
sativum (L),赤えんどう〕,グリシン・マ
ックス,メリル,〔Glycine max Merr
ill,くらかけ豆,がんくい豆,大豆,ひたし豆(青
大豆),黒豆,丹波大黒〕の種子部の水抽出物をイオン
交換クロマトグラフィーで精製したアンジオテンシン変
換酵素阻害活性を有する粗精製物に関する。[Industrial Application Field] The present invention is directed to the leguminous plant Phaseolus vulgaris (L.).
aris(L). Taisho Kintoki Bean, White Bean], Phaseolus coccineus (L)
coccineus (L). Tiger bean, purple-flowered bean, white-flowered bean], Phaseolus angularis. D'Avryu. F. Wight [Phaseolus angularis]
W. F. Wight, Azuki], Figna sinensis. Vigna sineusis Endl
.. Cowpea], Pisum sativum (L.)
sativum (L), red pea], glycine max, Merr
A crude product with angiotensin-converting enzyme inhibitory activity purified by ion-exchange chromatography from the aqueous extract of the seeds of Ill, Kurakake beans, Gankui beans, soybeans, hitashi beans (green soybeans), black soybeans, and Tamba Daikoku. Regarding.
【0002】0002
【従来の技術】アンジオテンシン変換酵素は主として肺
、血管内皮細胞、腎近位尿細管等に存在し、アンジオテ
ンシンIに作用して、そのC末端よりジペプチドを切断
して強力な昇圧作用を有するアンジオテンシンIIに変
換する酵素である。また、この酵素は生体内の降圧物質
であるブラジキニンを破壊し、不活化する作用も有して
おり、二重に昇圧系に関与していることが知られている
。従来、このアンジオテンシン変換酵素の活性を阻害す
れば、降圧に働き、臨床的には、高血圧症の予防あるい
は治療に有効であると考えられている。[Prior Art] Angiotensin-converting enzyme exists mainly in the lungs, vascular endothelial cells, renal proximal tubules, etc., and acts on angiotensin I to cleave a dipeptide from its C-terminus, resulting in angiotensin II, which has a strong pressor effect. It is an enzyme that converts This enzyme also has the effect of destroying and inactivating bradykinin, a hypotensive substance in living organisms, and is known to be doubly involved in the pressor system. It has been conventionally believed that inhibiting the activity of angiotensin-converting enzyme lowers blood pressure and is clinically effective in preventing or treating hypertension.
【0003】このような作業仮説のもとに医薬品として
開発されたのが、カプトプリルやエナラプリルである。
これらの薬剤は合成品である。一方天然に見出されるア
ンジオテンシン変換酵素阻害物質は極めて稀であり、わ
ずかにブラジル産や日本産の蛇毒より得られたアミノ酸
9個からなるペプチド物質(プロタイド,SQ2088
1)やストレプトマイセス属に属する放線菌の代謝産物
1583(特開昭58−177920号)が知られてい
るにすぎない。Captopril and enalapril were developed as pharmaceuticals based on this working hypothesis. These drugs are synthetic. On the other hand, angiotensin-converting enzyme inhibitors found in nature are extremely rare, and only a peptide substance (Protide, SQ2088) consisting of 9 amino acids obtained from snake venom from Brazil and Japan.
1) and the metabolite 1583 of actinomycetes belonging to the genus Streptomyces (Japanese Unexamined Patent Publication No. 177920/1983) are only known.
【0004】また最近では、蛋白質をプロテアーゼ類で
処理して得られるアンジオテンシン変換酵素阻害物質と
して、牛乳カゼインをトリプシンにより分解して得られ
るペプチド類が知られているに過ぎない。(特開昭58
−10942号,同59−44323号,同59−44
324号,同61−36226号,同61−36227
号)。[0004] Recently, only peptides obtained by decomposing milk casein with trypsin have been known as angiotensin converting enzyme inhibitors obtained by treating proteins with proteases. (Unexamined Japanese Patent Publication No. 58
-10942, 59-44323, 59-44
No. 324, No. 61-36226, No. 61-36227
issue).
【0005】[0005]
【発明が解決しようとする問題点】このような従来技術
の背景をもとに、本発明者らは、豆科植物の種子を、な
んら酵素処理をすることなく、天然のままに存在してい
るアンジオテンシン変換酵素阻害活性物質を探索したと
ころ、大正キントキ豆、白いんげん、とら豆、紫花豆、
白花豆、あずき、ささげ、赤えんどう、くらかけ豆、が
んくい豆、大豆、ひたし豆(青大豆)、黒豆、丹波大黒
等の水抽出物にアンジオテンシン変換酵素阻害活性を有
する物質が存在することを見出し、鋭意研究をした結果
、本発明完成をするに至った。[Problems to be Solved by the Invention] Based on the background of the prior art, the present inventors have developed a method for producing seeds of leguminous plants in their natural state without any enzyme treatment. When we searched for angiotensin-converting enzyme inhibiting substances, we found Taisho Kintoki beans, white beans, tiger beans, purple flower beans,
Substances that have angiotensin-converting enzyme inhibitory activity are present in aqueous extracts of white flower beans, azuki beans, cowpeas, red peas, black beans, hard beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku, etc. As a result of this discovery and extensive research, we have completed the present invention.
【0006】すなわち、本発明は常用食品素材すなわち
種子中に含まれる有効成分であって、副作用が少く使用
し易く、通常の食物として摂取することも可能であり、
また有効成分のみを抽出精製すれば優れた医薬品として
提供できるものである。[0006] That is, the present invention is an active ingredient contained in a commonly used food material, that is, seeds, which has few side effects, is easy to use, and can be ingested as a normal food.
Moreover, if only the active ingredients are extracted and purified, it can be provided as an excellent medicine.
【0007】[0007]
【発明の具体的説明】本発明者らはこのような技術水準
のもとに、天然有機化合物を広く検索し、副作用の少い
アンジオテンシン変換酵素阻害物質をもとめ鋭意研究し
た結果、常用食品素材であるマメ科植物種子の水抽出物
中に強いアンジオテンシン変換酵素阻害活性を見出し、
その活性成分は各種イオン交換クロマトグラフィーによ
り吸脱着できる性質があることを見出した。[Detailed Description of the Invention] Based on the above-mentioned state of the art, the present inventors searched widely for natural organic compounds and conducted intensive research in search of an angiotensin-converting enzyme inhibitor with few side effects. We discovered strong angiotensin-converting enzyme inhibitory activity in the aqueous extract of certain legume seeds.
It was discovered that the active ingredient has the property of being able to be adsorbed and desorbed by various ion exchange chromatography methods.
【0008】一般に天然物からの活性成分の分離精製に
は活性成分のもつ物理化学的性質を利用して抽出精製を
行うのが常法である。[0008] In general, the conventional method for separating and purifying active ingredients from natural products is to perform extraction and purification using the physicochemical properties of the active ingredients.
【0009】本発明は、まず、大正キントキ豆、白いん
げん、とら豆、紫花豆、白花豆、あずき、ささげ、赤え
んどう、くらかけ豆、がんくい豆、大豆、ひたし豆(青
大豆)、黒豆、丹波大黒等の豆類を各々、別々にミキサ
ーで粉砕し、一定量の粉砕物をノルマルヘキサン、石油
エーテル、クロロホルム等の水と分別できる有機溶媒に
浸し、充分混和して、各種豆類に含まれる、脂質成分を
除去することが可能である。[0009] The present invention first uses Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black beans, hard beans, soybeans, hitashi beans (green soybeans) Pulses such as , black soybeans, and Tamba Daikoku are ground separately in a mixer, and a certain amount of the ground material is immersed in an organic solvent that can be separated from water, such as n-hexane, petroleum ether, or chloroform, and thoroughly mixed to produce various beans. It is possible to remove the contained lipid components.
【0010】また、上記豆類から、除タンパクを行うた
めには、通常は水と混和できる溶剤、例えば、エタノー
ル、メタノール、アセトンなど、あるいは、無機塩類を
加えて、沈澱せしめる塩析法や、トリクロロ酢酸を加え
て沈澱物を取り除く方法など、通常行われているあらゆ
る除タンパクの方法が適用できる。[0010] In addition, in order to remove protein from the above-mentioned legumes, usually a water-miscible solvent such as ethanol, methanol, acetone, etc., or a salting-out method in which precipitation is performed by adding inorganic salts, or trichloromethane are used. Any commonly used protein removal methods can be applied, such as adding acetic acid to remove precipitates.
【0011】このようにして脱脂質、脱タンパクを行っ
た各種豆科植物の種子の水抽出液のアンジオテンシン変
換酵素阻害活性をヒップリルーヒスチジル−ロイシン(
Hip−His−Leu)を基質に用い、クッシュマン
法(ディ−・ダヴリュ・クッシュマンらバイオケミカル
ファーマコロジー20巻、1637頁、1971年〔D
.W.Cushman etal,Biochem.
Phamacol. 20,1637(1971)〕を
一部改変した方法で測定した結果、大正キントキ豆、白
いんげん、とら豆、紫花豆、白花豆、あずき、ささげ、
赤えんどう、くらかけ豆、がんくい豆、大豆、ひたし豆
(青大豆)黒豆、丹波大黒等のすべての豆種子中に強力
な阻害活性を認めた。The angiotensin-converting enzyme inhibitory activity of the aqueous extracts of the seeds of various leguminous plants that have been delipidated and deproteinized in this manner was determined by hip-lyr-histidyl-leucine (
Hip-His-Leu) was used as a substrate, and the Cushman method (D.
.. W. Cushman et al., Biochem.
Pharmacol. 20, 1637 (1971)], the results were as follows: Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas,
Strong inhibitory activity was observed in all soybean seeds such as red peas, kurakake beans, gankui beans, soybeans, hitashi beans (green soybeans), black beans, and Tamba Daikoku.
【0012】さらに各種豆科植物の種子から得られた水
抽出液をイオン交換クロマトグラフィー、例えば、陽イ
オン交換樹脂としては、アンバーライトIR−120(
ロームアンドハース社製)ダウエックス50W(ダウケ
ミカル社製)、ダイヤイオンSK1A(三菱化成社製)
、また陰イオン交換樹脂として例えば、アンバーライト
IRA402,IRA68(ロームアンドハース社製)
、ダウエックス1(ダウケミカル社製)、ダイヤイオン
SA10B,PA−404,WA−30(三菱化成社製
)などを用いて吸着せしめ、塩、アルカリ、あるいは酸
を含む水溶液あるいは緩衝液などで容易に、本発明のア
ンジオテンシン変換酵素阻害剤が得られる。得られた分
画を前記クッシュマン法の一部改変した測定法で測定す
ると大正キントキ豆、白いんげん、とら豆、紫花豆、白
花豆、あずき、ささげ、赤えんどう、くらかけ豆、がん
くい豆、大豆、ひたし豆(青大豆)、黒豆、丹波大黒等
の水抽出物をそれぞれイオン交換クロマトグラフィーで
精製した各々の粗精製物に強い阻害活性を認めた。Furthermore, aqueous extracts obtained from seeds of various leguminous plants are subjected to ion exchange chromatography, such as Amberlite IR-120 (as a cation exchange resin).
(manufactured by Rohm and Haas) DOWEX 50W (manufactured by Dow Chemical), Diaion SK1A (manufactured by Mitsubishi Kasei)
, and anion exchange resins such as Amberlite IRA402 and IRA68 (manufactured by Rohm and Haas)
, DOWEX 1 (manufactured by Dow Chemical Company), DIAION SA10B, PA-404, WA-30 (manufactured by Mitsubishi Chemical Corporation), etc., and easily adsorbed with an aqueous solution or buffer containing salt, alkali, or acid. In this way, the angiotensin converting enzyme inhibitor of the present invention is obtained. When the obtained fractions were measured using a partially modified measurement method of the above-mentioned Cushman method, Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black beans, and ganku beans were detected. Strong inhibitory activity was observed in each of the crudely purified water extracts of beans, soybeans, hitashi beans (green soybeans), black soybeans, Tamba Daikoku, etc., each purified by ion exchange chromatography.
【0013】本発明によれば、大正キントキ豆、白いん
げん、とら豆、紫花豆、白花豆、あずき、ささげ、赤え
んどう、くらかけ豆、がんくい豆、大豆、ひたし豆(青
大豆)、黒豆、丹波大黒等の植物種子に特異的に含まれ
ているアンジオテンシン変換酵素阻害物質を、多量混在
している不純物から効率よく分別することができる。According to the present invention, Taisho Kintoki beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black beans, hard beans, soybeans, hitashi beans (green soybeans) Angiotensin-converting enzyme inhibitors, which are specifically contained in plant seeds such as , black soybeans, and Tamba Daikoku, can be efficiently separated from impurities that are present in large quantities.
【0014】本発明のアンジオテンシン変換酵素阻害物
質はpH7.5において90℃、30分の熱処理に対し
安定であり、セロファン膜によって透析される。The angiotensin-converting enzyme inhibitor of the present invention is stable to heat treatment at 90° C. for 30 minutes at pH 7.5, and is dialyzed through a cellophane membrane.
【0015】[0015]
【発明の効果】本発明の大正キントキ豆、白いんげん、
とら豆、紫花豆、白花豆、あずき、ささげ、赤えんどう
、くらかけ豆、がんくい豆、大豆、ひたし豆(青大豆)
、黒豆、丹波大黒等の豆科植物種子中より得られた水抽
出物およびイオン交換クロマトグラフィーで得られた粗
抽出物中には強力なアンジオテンシン変換酵素阻害活性
を示し、血圧降下作用、ブラジキニン不活化抑制作用を
示し、本態性高血圧、腎性高血圧、副腎性高血圧などの
高血圧症の予防、治療、これら疾患の診断薬や各種病態
において用いられる血圧降下剤として有用である。[Effects of the invention] Taisho Kintoki beans, white beans,
Tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, black peas, hard beans, soybeans, hitashi beans (green soybeans)
Aqueous extracts obtained from the seeds of leguminous plants such as black soybeans and Tamba Daikoku, and crude extracts obtained by ion-exchange chromatography, exhibit strong angiotensin-converting enzyme inhibitory activity and have antihypertensive effects and bradykinin inhibition. It exhibits an activation-suppressing effect and is useful for the prevention and treatment of hypertension such as essential hypertension, renal hypertension, and adrenal hypertension, as a diagnostic agent for these diseases, and as a hypotensive agent used in various pathological conditions.
【0016】一方、本発明は常用食品素材から抽出、精
製したものであって、通常の食品中に含まれる食品成分
であり、この点から観て、副作用等による影響は極めて
少ないものと予測される。On the other hand, the present invention is extracted and purified from commonly used food materials, and is a food ingredient contained in common foods.From this point of view, it is expected that there will be very little influence from side effects. Ru.
【0017】したがって、本発明の水抽出物および粗精
製物は前記に示した血圧降下作用という重要な生理活性
を有しており、普通、食用としている豆科植物種子中に
食品のもつ機能特性が発揮されることを考え併せば、機
能性食品の重要な食品素材としても有用である。[0017] Therefore, the aqueous extract and crudely purified product of the present invention have the important physiological activity of lowering blood pressure as shown above, and have the functional properties of food in leguminous plant seeds that are commonly eaten. Considering that it exhibits the following properties, it is also useful as an important food ingredient for functional foods.
【0018】以下に実施例を 掲記し本発明をさらに
詳細に説明する。[0018] The present invention will be explained in more detail with reference to Examples below.
【0019】[0019]
【実施例】I.水抽出物の取得
市販の大正キントキ豆、白いんげん、とら豆、紫花豆、
白花豆、あずき、ささげ、赤えんどう、くらかけ豆、大
豆、ひたし豆(青大豆)、黒豆、丹波大黒等の種子各々
20gずつをミキサーで5分間粉砕し、30メッシュの
篩を通して各々の粉砕物を得た。[Example] I. Obtaining water extracts Commercially available Taisho Kintoki beans, white beans, tiger beans, purple flower beans,
Grind 20g each of seeds such as white flower beans, azuki beans, cowpeas, red peas, black beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku, etc. for 5 minutes with a mixer, and pass through a 30-mesh sieve. I got something.
【0020】各々の粉砕物にそれぞれ8mlのノルマル
ヘキサンを加え1時間撹拌してノルマルヘキサンを濾別
した。再び8mlのノルマルヘキサンをそれぞれに加え
同様の操作を行った。それぞれの残渣を風乾し、脱脂し
た風乾物を得た。8 ml of n-hexane was added to each of the pulverized products and stirred for 1 hour, and the n-hexane was filtered off. Again, 8 ml of n-hexane was added to each and the same operation was performed. Each residue was air-dried to obtain a defatted air-dried product.
【0021】上記それぞれの風乾物に8mlの水を加え
、よく混和すると黄褐色から黄色の粘稠な液が得られ、
これらの液に8mlのエタノールを加えて、再びよく混
和すると不溶部分と白色沈殿物が生じた。生じた沈殿物
を10,000r.p.m.20分間遠心分離を行いそ
れぞれ粘性のない上澄液約14mlずつを得た。このよ
うにして得られた上澄液を40℃で減圧濃縮後、凍結乾
燥をして下記に示したそれぞれの水抽出物を得た。(第
1表)これらの水抽出物についてアンジオテンシン変換
酵素阻害活性を調べた。Add 8 ml of water to each of the above air-dried products and mix well to obtain a yellowish brown to yellow viscous liquid.
When 8 ml of ethanol was added to these solutions and mixed well again, an insoluble portion and a white precipitate were generated. The resulting precipitate was heated to 10,000r. p. m. Centrifugation was performed for 20 minutes to obtain approximately 14 ml of non-viscous supernatant liquid. The supernatant thus obtained was concentrated under reduced pressure at 40° C. and then freeze-dried to obtain the respective aqueous extracts shown below. (Table 1) These aqueous extracts were examined for angiotensin converting enzyme inhibitory activity.
【0022】[0022]
【表1】
II. 粗精製物の取得
大正キントン豆、白いんげん、とら豆、紫花豆、白花豆
、あずき、ささげ、赤えんどう、くらかけ豆、大豆、ひ
たし豆(青大豆)、黒豆、丹波大黒等の水抽出物2gを
水20mlにそれぞれ溶解し、IN塩酸でpH5.0に
調整後、アンバーライトIR−120(H+ 型)のイ
オン交換カラムクロマト(カラム:直径1.5cm×高
さ10cm)に通液し吸着後、30mlの水で充分水洗
し、次いで0.3Nのアンモニヤ水50mlで溶出した
。[Table 1] II. Acquisition of crude refined products Water extraction of Taisho Kinton beans, white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, kurakake beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku, etc. Dissolve 2 g of each in 20 ml of water, adjust the pH to 5.0 with IN hydrochloric acid, and pass through an ion exchange column chromatograph (column: diameter 1.5 cm x height 10 cm) of Amberlite IR-120 (H+ type). After adsorption, the mixture was thoroughly washed with 30 ml of water, and then eluted with 50 ml of 0.3N aqueous ammonia.
【0023】それぞれの溶出液を減圧F40℃でアンモ
ニヤを回収後、凍結乾燥して、第2表に示したそれぞれ
の粗精製物を得た。[0023] After recovering ammonia from each eluate under reduced pressure at F40°C, it was freeze-dried to obtain each crude product shown in Table 2.
【0024】これらの粗精製物についてアンジオテンシ
ン変換酵素阻害活性を調べた。[0024] These crude products were examined for angiotensin converting enzyme inhibitory activity.
【0025】[0025]
【表2】
III.アンジオテンシン変換酵素阻害活性の測定実験
材料(1)アンジオテンシン変換酵素:ウサギ肺のアン
ジオテンシン変換酵素をシグマ化学社より購入(2)ア
ンジオテンシン変換酵素阻害物質前記実施例I,II項
で得られた26検体
(3)酵素基質[Table 2] III. Experimental materials for measuring angiotensin-converting enzyme inhibitory activity (1) Angiotensin-converting enzyme: rabbit lung angiotensin-converting enzyme purchased from Sigma Chemical Co., Ltd. (2) Angiotensin-converting enzyme inhibitor 26 samples obtained in Examples I and II above ( 3) Enzyme substrate
【0026】[0026]
【化1】 IV. アンジオテンシン変換酵素阻害活性の測定。[Chemical formula 1] IV. Measurement of angiotensin converting enzyme inhibitory activity.
【0027】アンジオテンシン変換酵素阻害活性の測定
法は各々の検体の存在下と、検体の非存在下におけるア
ンジオテンシン変換酵素の酵素活性を測定し、これと求
められた阻害率から各検体の阻害活性IC50を算出し
た。The method for measuring angiotensin converting enzyme inhibitory activity is to measure the enzyme activity of angiotensin converting enzyme in the presence and absence of each specimen, and from this and the determined inhibition rate, the inhibitory activity IC50 of each specimen is determined. was calculated.
【0028】なお、アンジオテンシン変換酵素活性の測
定は、前記クッシュマンの方法に従い、さらにハヤカリ
らの変法〔アナリティカルバイオケミストリー84巻、
361頁1978年;Anal.Biochem. 8
4,361(1978)〕を採用して以下のごとくに行
った。[0028] The angiotensin converting enzyme activity was measured according to the method of Cushman and a modified method of Hayakari et al. [Analytical Biochemistry Vol. 84,
361 pages 1978; Anal. Biochem. 8
4,361 (1978)] was adopted as follows.
【0029】すなわち50mMのトリス塩酸緩衝液(p
H8.2)、0.3Mの塩化ナトリウム水溶液、2mM
のHip−His−Leu の基質、ウサギの肺由来の
アンジオテンシン変換酵素(1〜2ミリユニット)およ
び、各検体を含む酵素反応液250μl を37℃30
分間インキュベートした。That is, 50mM Tris-HCl buffer (p
H8.2), 0.3M sodium chloride aqueous solution, 2mM
250 μl of enzyme reaction solution containing Hip-His-Leu substrate, rabbit lung-derived angiotensin converting enzyme (1-2 milliunits), and each sample was heated at 37°C.
Incubated for minutes.
【0030】次いで、IN水酸化ナトリウム水溶液15
μl を加えて反応を停止し、室温にて、30分間放置
後、60mMのリン酸ナトリウム緩衝液(pH7.2)
1mlと1%シアヌール酸クロライドを含むメチルセロ
ソルブ1mlを加えて、15分間放置後382nmの吸
光度を測定した。Next, IN sodium hydroxide aqueous solution 15
The reaction was stopped by adding μl of 60mM sodium phosphate buffer (pH 7.2) and left at room temperature for 30 minutes.
1 ml of methyl cellosolve containing 1% cyanuric acid chloride was added thereto, and after being left for 15 minutes, the absorbance at 382 nm was measured.
【0031】各々の検体を含む反応液の吸光度(a)と
検体を含まない吸光度(b)と、それぞれに対する反応
しない盲検の吸光度(a´およびb´)から阻害率を次
式により求めた。[0031] The inhibition rate was calculated from the absorbance of the reaction solution containing each sample (a), the absorbance without the sample (b), and the absorbance of a blind sample that did not react to each (a' and b') using the following formula. .
【0032】[0032]
【数1】
上記測定法にもとずき、検体のいくつかの濃度における
阻害率を求め、50%阻害濃度(IC50)を算出した
。[Equation 1] Based on the above measurement method, the inhibition rate at several concentrations of the specimen was determined, and the 50% inhibitory concentration (IC50) was calculated.
【0033】V.実験結果、本発明の大正キントキ豆、
白いんげん、とら豆、紫花豆、白花豆、あずき、ささげ
、赤えんどう、くらかけ豆、がんくい豆、大豆、ひたし
豆(青大豆)、黒豆、丹波大黒由来の各々の水抽出物及
び各々の粗精製物のアンジオテンシン変換酵素に対する
阻害活性は第3表に示すとおりであり、実施例で工程I
において得られた抽出物に対して10〜13倍の活性上
昇が認められた。[0033]V. Experimental results show that the Taisho Kintoki beans of the present invention,
Each water extract derived from white beans, tiger beans, purple flower beans, white flower beans, azuki beans, cowpeas, red peas, kurakake beans, hard beans, soybeans, hitashi beans (green soybeans), black beans, Tamba Daikoku and The inhibitory activity of each crude product against angiotensin converting enzyme is as shown in Table 3.
A 10- to 13-fold increase in activity was observed compared to the extract obtained in .
【0034】[0034]
【表3】[Table 3]
Claims (2)
有する豆科植物である、ファゼオラス ブルガリス(
エル)、ファゼオラス コクシネウス(エル)、ファ
ゼオラス アンギュラリス ダヴリュ.エフ.ワイ
ト、フィグナ シネンシス.エンドル、ピスム サ
チブム(エル)、グリシン マックス メリルの種
子からの水抽出物。Claim 1: Phaseolus vulgaris, a leguminous plant that has angiotensin-converting enzyme inhibitory activity.
(L), Phaseolus coccineus (L), Phaseolus angularis (L). F. Wight, Figna sinensis. Aqueous extract from seeds of Endor, Pisum sativum (L.), Glycine max meryl.
媒により脂質脂肪酸などの不純物を除去し、次いでイオ
ン交換クロマトグラフィーで精製されることを特徴とす
る特許請求の第1項記載のアンジオテンシン変換酵素阻
害活性を有する物質、即ち、アンジオテンシン変換酵素
降圧剤及びその製法。2. The angiotensin according to claim 1, wherein impurities such as lipids and fatty acids are removed from the aqueous extract of each bean seed using an organic solvent, and then purified by ion exchange chromatography. A substance having converting enzyme inhibitory activity, that is, an angiotensin converting enzyme antihypertensive agent, and a method for producing the same.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3040511A JPH04261122A (en) | 1991-02-13 | 1991-02-13 | Angiotensinase activity inhibitor contained in leguminous plant seed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3040511A JPH04261122A (en) | 1991-02-13 | 1991-02-13 | Angiotensinase activity inhibitor contained in leguminous plant seed |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04261122A true JPH04261122A (en) | 1992-09-17 |
Family
ID=12582570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3040511A Pending JPH04261122A (en) | 1991-02-13 | 1991-02-13 | Angiotensinase activity inhibitor contained in leguminous plant seed |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04261122A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0549432A (en) * | 1991-08-23 | 1993-03-02 | Takano Co Ltd | Food additive |
US6949263B2 (en) * | 2000-12-11 | 2005-09-27 | Kikkoman Corporation | Method for preparing nicotianamine or nicotianamine-containing product |
JP2010053125A (en) * | 2008-07-28 | 2010-03-11 | Nisshin Pharma Inc | Anti-allergic agent |
JP2010229069A (en) * | 2009-03-26 | 2010-10-14 | Aomori Univ Of Health & Welfare | Agent for preventing and ameliorating arteriosclerosis and method for preventing arteriosclerosis |
WO2011080825A1 (en) * | 2009-12-28 | 2011-07-07 | 日清ファルマ株式会社 | Anti-allergic agent |
-
1991
- 1991-02-13 JP JP3040511A patent/JPH04261122A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0549432A (en) * | 1991-08-23 | 1993-03-02 | Takano Co Ltd | Food additive |
JP2505330B2 (en) * | 1991-08-23 | 1996-06-05 | タカノ株式会社 | Food additive |
US6949263B2 (en) * | 2000-12-11 | 2005-09-27 | Kikkoman Corporation | Method for preparing nicotianamine or nicotianamine-containing product |
JP2010053125A (en) * | 2008-07-28 | 2010-03-11 | Nisshin Pharma Inc | Anti-allergic agent |
JP2010229069A (en) * | 2009-03-26 | 2010-10-14 | Aomori Univ Of Health & Welfare | Agent for preventing and ameliorating arteriosclerosis and method for preventing arteriosclerosis |
WO2011080825A1 (en) * | 2009-12-28 | 2011-07-07 | 日清ファルマ株式会社 | Anti-allergic agent |
CN102711782A (en) * | 2009-12-28 | 2012-10-03 | 日清药业股份有限公司 | Anti-allergic agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2145630B1 (en) | Angiotensin-converting enzyme inhibitory peptides | |
Wang et al. | Isolation and identification of a novel peptide from zein with antioxidant and antihypertensive activities | |
KR20060118395A (en) | Casein hydrolyzate, process for producing the same and use thereof | |
JPH04261122A (en) | Angiotensinase activity inhibitor contained in leguminous plant seed | |
KR20150036167A (en) | Angiotensin-converting-enzyme inhibiting dipeptide | |
JP4790325B2 (en) | Antihypertensive peptide derived from meat protein | |
JPH06256387A (en) | New peptide, its production and hypotensive agent comprising the same as active ingredient | |
Yu et al. | Preparation and function of oligopeptide-enriched hydrolysate from globin by pepsin | |
JP2002088098A (en) | Pearl oyster-originating ace-inhibitory peptide | |
JP3651878B2 (en) | Antihypertensive peptide derived from meat protein | |
JP2873327B2 (en) | Angiotensin converting enzyme inhibitor | |
JP3406341B2 (en) | New peptides, their production methods and applications | |
KR100295739B1 (en) | Angiotensin I Converting Enzyme Inhibitor | |
JP3401280B2 (en) | New peptides, their production methods and applications | |
Aoyagi et al. | Constituents of a cationic peptide-rich fraction of Lentinus edodes | |
KR100367782B1 (en) | Preperation of peptide from laver having inhibitory activity against angiotensin converting enzyme | |
KR0150798B1 (en) | Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides | |
JPH01313498A (en) | Novel peptide &m:a peptide of the formula. | |
JPH04164094A (en) | New peptide, its production and angiotensin converting enzyme inhibitor containing the same peptide as active ingredient | |
JPH04139196A (en) | New peptide, its production and use thereof | |
EP2548458B1 (en) | Lupin-derived compounds having hypotensive activity and process for their production | |
JPH07313185A (en) | Production of peptide | |
JPH02282394A (en) | New peptide and hypotensive agent | |
Bauer et al. | Novel microbial inhibitors of ACE* Isolation and characterization | |
KR20050027239A (en) | Process for obtaining serine proteinase inhibitor from canavalia gladiata |